GIP receptor antagonist and GLP-1 receptor agonist

Mari iv

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

MARI_IV

Mechanism: Antibody peptide conjugate (maridebart cafraglutide)
Trials: 0
Participants in these arms: 0

Doses in this pooled treatment

Mari iv 70mg other

Mari iv

Doses in this pooled treatment

Trials